Claudio Scuoppo

2.8k total citations · 1 hit paper
27 papers, 1.9k citations indexed

About

Claudio Scuoppo is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Claudio Scuoppo has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Claudio Scuoppo's work include Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Claudio Scuoppo is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Claudio Scuoppo collaborates with scholars based in United States, Italy and Canada. Claudio Scuoppo's co-authors include Scott W. Lowe, Prem K. Premsrirut, Scott C. Kogan, Brian M. Balgley, Xueping Fang, Xiaowo Wang, Agustin Chicas, Cheng S. Lee, Jessica E. Bolden and Yuchen Chien and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Claudio Scuoppo

24 papers receiving 1.9k citations

Hit Papers

Control of the senescence-associated secretory phenotype ... 2011 2026 2016 2021 2011 250 500 750

Peers

Claudio Scuoppo
Günter Daum United States
Steven Swendeman United States
Paul J. Coffer Netherlands
Prem K. Premsrirut United States
Hao Ding Canada
Günter Daum United States
Claudio Scuoppo
Citations per year, relative to Claudio Scuoppo Claudio Scuoppo (= 1×) peers Günter Daum

Countries citing papers authored by Claudio Scuoppo

Since Specialization
Citations

This map shows the geographic impact of Claudio Scuoppo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Scuoppo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Scuoppo more than expected).

Fields of papers citing papers by Claudio Scuoppo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Scuoppo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Scuoppo. The network helps show where Claudio Scuoppo may publish in the future.

Co-authorship network of co-authors of Claudio Scuoppo

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Scuoppo. A scholar is included among the top collaborators of Claudio Scuoppo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Scuoppo. Claudio Scuoppo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scuoppo, Claudio, Karen Mendelson, Lila Ghamsari, et al.. (2025). The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses. Frontiers in Immunology. 16. 1522699–1522699. 1 indexed citations
2.
Scuoppo, Claudio, Cai Bowen, Kenneth Ofori, et al.. (2024). Repurposing NAMPT Inhibitors for Germinal Center B Cell–Like Diffuse Large B-Cell Lymphoma. Blood Cancer Discovery. 5(6). 417–427.
3.
Palma, Alessandro, et al.. (2023). A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription Termination. Biomedicines. 11(2). 412–412. 5 indexed citations
4.
Chen, Xiao, Yinglu Li, Fang Zhu, et al.. (2023). Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma. Nature Communications. 14(1). 4259–4259. 12 indexed citations
5.
Scuoppo, Claudio, Jiguang Wang, Mirjana Persaud, et al.. (2019). Repurposing dasatinib for diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences. 116(34). 16981–16986. 27 indexed citations
6.
Meyer, Stefanie N., Claudio Scuoppo, Sofija Vlasevska, et al.. (2019). Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma. Immunity. 51(3). 535–547.e9. 88 indexed citations
7.
Fabbri, Giulia, Antony B. Holmes, Claudio Scuoppo, et al.. (2017). Common nonmutationalNOTCH1activation in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences. 114(14). E2911–E2919. 91 indexed citations
8.
Miething, Cornelius, Claudio Scuoppo, Benedikt Bosbach, et al.. (2014). PTEN action in leukaemia dictated by the tissue microenvironment. Nature. 510(7505). 402–406. 38 indexed citations
9.
Chakraborty, Abhishek A., Claudio Scuoppo, Swati Dey, et al.. (2014). A common functional consequence of tumor-derived mutations within c-MYC. Oncogene. 34(18). 2406–2409. 22 indexed citations
10.
Appelmann, Iris, Claudio Scuoppo, Vishal Thapar, et al.. (2014). Suppression of EZH2 Accelerates MYC-Driven Lymphomagenesis By Inhibition of Apoptosis. Blood. 124(21). 3009–3009. 1 indexed citations
11.
Chatterjee, Samit, Michael E. Feigin, Don L. Gibbons, et al.. (2012). Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells. PLoS ONE. 7(4). e34343–e34343. 30 indexed citations
12.
Scuoppo, Claudio, Cornelius Miething, Lisa Lindqvist, et al.. (2012). A tumour suppressor network relying on the polyamine–hypusine axis. Nature. 487(7406). 244–248. 104 indexed citations
13.
Premsrirut, Prem K., Lukas E. Dow, Sang Yong Kim, et al.. (2011). A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference. Cell. 145(1). 145–158. 235 indexed citations
14.
Chien, Yuchen, Claudio Scuoppo, Xiaowo Wang, et al.. (2011). Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes & Development. 25(20). 2125–2136. 757 indexed citations breakdown →
15.
Bric, Anka, Cornelius Miething, Carl Uli Bialucha, et al.. (2009). Functional Identification of Tumor-Suppressor Genes through an In Vivo RNA Interference Screen in a Mouse Lymphoma Model. Cancer Cell. 16(4). 324–335. 140 indexed citations
16.
Scuoppo, Claudio, Paola Allegra, Paolo E. Forni, et al.. (2007). The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes. Experimental Cell Research. 313(11). 2308–2317. 15 indexed citations
17.
Taulli, Riccardo, Claudio Scuoppo, Francesca Bersani, et al.. (2006). Validation of Met as a Therapeutic Target in Alveolar and Embryonal Rhabdomyosarcoma. Cancer Research. 66(9). 4742–4749. 131 indexed citations
18.
Forni, Paolo E., Claudio Scuoppo, Itaru Imayoshi, et al.. (2006). High Levels of Cre Expression in Neuronal Progenitors Cause Defects in Brain Development Leading to Microencephaly and Hydrocephaly. Journal of Neuroscience. 26(37). 9593–9602. 134 indexed citations
19.
Crepaldi, Tiziana, Francesca Bersani, Claudio Scuoppo, et al.. (2006). Conditional Activation of MET in Differentiated Skeletal Muscle Induces Atrophy. Journal of Biological Chemistry. 282(9). 6812–6822. 23 indexed citations
20.
Taulli, Riccardo, Paolo Accornero, Antonia Follenzi, et al.. (2005). RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis. Cancer Gene Therapy. 12(5). 456–463. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026